Hasta la próxima

Auto reproducción

Novel Agents and Combinations in Hodgkin Lymphoma

0 vistas • 07/09/23
Compartir
Empotrar
administrator
administrator
Suscriptores
0

Panelists discuss novel agents, such as HDAC inhibitors, being explored in clinical trials for patients with Hodgkin lymphoma.

For more from this discussion, visit http://www.onclive.com/peer-exchange/lymphoma

Mostrar más
0 Comentarios sort Ordenar por
Comentarios de Facebook

Hasta la próxima

Auto reproducción